Mutations associated with epileptic encephalopathy modify EAAT2 anion channel function.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Mutations in the solute carrier family member 1A2 (SLC1A2) gene, encoding excitatory amino acid transporter 2 (EAAT2), are linked to severe epileptic encephalopathies.
• EAAT2 is crucial for clearing glutamate from the synaptic cleft, functioning as both a transporter and an anion channel.
• The precise impact of naturally occurring mutations on EAAT2's dual transport functions and their role in epilepsy pathogenesis remains unclear.

Purpose of the Study:

• To investigate the functional consequences of three disease-associated EAAT2 mutations (G82R, L85P, P289R).
• To elucidate how these mutations affect EAAT2's l-glutamate transport and anion channel activity.
• To understand the molecular mechanisms underlying EAAT2-associated epilepsy.

Main Methods:

• Heterologous expression of mutant EAAT2 in mammalian cells.
• Biochemical assays to assess protein expression and function.
• Confocal imaging to determine cellular localization.
• Whole-cell patch-clamp recordings to measure l-glutamate uptake and anion currents.

Main Results:

• Mutations G82R and L85P alter the EAAT2 anion pore, enabling l-glutamate efflux and acting as efflux pathways.
• Mutation P289R reduces l-glutamate uptake and increases anion currents, despite decreased membrane expression.
• These findings reveal an unexpected l-glutamate permeability through the EAAT2 anion pore.

Conclusions:

• Naturally occurring EAAT2 mutations can unexpectedly confer l-glutamate permeability to the anion pore.
• Glutamate efflux via mutant EAAT2 channels can cause excitotoxicity and neuronal hyperexcitability in patients.
• Targeting EAAT2 anion channel activity with selective antagonists may offer future therapeutic strategies for epilepsy.